Complejo Hospitalario Universitario A Coruna

A Coruña, LA Coruna 15006

0 studies enrolling now · 2 studies all time

What they study most

ALK-positive Advanced NSCLC, Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib — Completed